Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Rs, Gelman"'
Autor:
Rs Gelman, Wende Levy, Ram Yogev, E. Richard Stiehm, Stephen A. Spector, W.T. Shearer, Sd Douglas, Katherine Luzuriaga, Howard M. Rosenblatt, R Oyomopito, Elizabeth J. McFarland, Mobeen H. Rathore, Bl Graham, Diane W. Wara
Publikováno v:
Journal of Allergy and Clinical Immunology. 109:S199-S199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9749d263e5f69f264dc196d6554c75b3
https://doi.org/10.1016/s0091-6749(02)81732-8
https://doi.org/10.1016/s0091-6749(02)81732-8
Autor:
Joern E Schmitz, Ma, Forman, Ma, Lifton, Concepción O, Ka, Reimann, Cs, Crumpacker, Jf, Daley, Rs, Gelman, Nl, Letvin
Publikováno v:
Europe PubMed Central
CD8(+) T lymphocytes play a pivotal role in controlling human immunodeficiency virus (HIV)-1 replication in vivo. We have performed four-color flow cytometric analysis of CD8(+) peripheral blood lymphocytes (PBL) from 21 HIV-1 seronegative and 103 se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7096f4efe89feffd771093d3a8f69578
http://europepmc.org/abstract/med/9639517
http://europepmc.org/abstract/med/9639517
Autor:
Rana HQ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Stopfer JE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Weitz M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kipnis L; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Koeller DR; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Culver S; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Mercado J; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Gelman RS; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Underhill-Blazey M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., McGregor BA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Sweeney CJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Petrucelli N; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Kokenakes C; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Pirzadeh-Miller S; University of Texas Southwestern Medical Center, Dallas, TX., Reys B; University of Texas Southwestern Medical Center, Dallas, TX., Frazier A; Karmanos Cancer Institute at McLaren Clarkston, Clarkston, MI., Knechtl A; Karmanos Cancer Institute at McLaren Clarkston, Clarkston, MI., Fateh S; Karmanos Cancer Institute at McLaren Clarkston, Clarkston, MI., Vatnick DR; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Silver R; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Kilbridge KE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Pomerantz MM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Wei XX; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Choudhury AD; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Sonpavde GP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Kozyreva O; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lathan C; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Horton C; Ambry Genetics, Aliso Viejo, CA., Dolinsky JS; Ambry Genetics, Aliso Viejo, CA., Heath EI; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Ross TS; University of Texas Southwestern Medical Center, Dallas, TX., Courtney KD; University of Texas Southwestern Medical Center, Dallas, TX., Garber JE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Taplin ME; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2023 Nov; Vol. 19 (11), pp. 1069-1079. Date of Electronic Publication: 2023 Sep 21.
Autor:
Xu J; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02141, USA.; Harvard Medical School, Boston, USA.; Sanofi US, 50 Binney St, Cambridge, MA, 02142, USA., Keenan TE; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02141, USA.; Dana-Farber Cancer Institute, Boston, USA.; Harvard Medical School, Boston, USA., Overmoyer B; Dana-Farber Cancer Institute, Boston, USA.; Harvard Medical School, Boston, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, USA.; Harvard Medical School, Boston, USA., Gelman RS; Dana-Farber Cancer Institute, Boston, USA.; Harvard Medical School, Boston, USA., Habin K; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02141, USA., Garber JE; Dana-Farber Cancer Institute, Boston, USA.; Harvard Medical School, Boston, USA., Ellisen LW; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02141, USA.; Harvard Medical School, Boston, USA., Winer EP; Dana-Farber Cancer Institute, Boston, USA.; Harvard Medical School, Boston, USA., Goss PE; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02141, USA.; Harvard Medical School, Boston, USA., Yeap BY; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02141, USA.; Harvard Medical School, Boston, USA., Chabner BA; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02141, USA. BCHABNER@mgh.harvard.edu.; Harvard Medical School, Boston, USA. BCHABNER@mgh.harvard.edu., Isakoff SJ; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02141, USA.; Harvard Medical School, Boston, USA.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Oct; Vol. 189 (3), pp. 641-651. Date of Electronic Publication: 2021 Aug 20.
Autor:
Leone JP; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Emblem KE; Department of Diagnostic Physics, Oslo University Hospital, Oslo, Norway., Weitz M; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Gelman RS; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Schneider BP; Indiana University School of Medicine, Indianapolis, IN, USA., Freedman RA; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Younger J; Massachusetts General Hospital, Boston, MA, USA., Pinho MC; University of Texas Southwestern Medical Center, Dallas, TX, USA., Sorensen AG; IMRIS Inc., Minnetonka, MN, USA., Gerstner ER; Massachusetts General Hospital, Boston, MA, USA., Harris G; Massachusetts General Hospital, Boston, MA, USA., Krop IE; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Morganstern D; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Sohl J; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Hu J; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Kasparian E; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Winer EP; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Lin NU; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA. nlin@partners.org.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2020 Nov 30; Vol. 22 (1), pp. 131. Date of Electronic Publication: 2020 Nov 30.
Autor:
Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: rafreedman@partners.org., Gelman RS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA., Agar NYR; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Randall EC; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA., Gimenez-Cassina Lopez B; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA., Connolly RM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Dunn IF; Department of Neurosurgery, University of Oklahoma, Oklahoma City, OK., Van Poznak CH; University of Michigan, Ann Arbor, MI., Anders CK; Division of Medical Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC., Melisko ME; Department of Medical Oncology, University of California at San Francisco, San Francisco, CA., Silvestri K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cotter CM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Componeschi KP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Marte JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Moy B; Massachusetts General Hospital, Boston, MA., Blackwell KL; Department of Medicine, Duke University Medical Center, Durham, NC., Puhalla SL; University of Pittsburgh Cancer Institute, Magee-Women's Hospital, Pittsburgh, PA., Ibrahim N; The University of Texas MD Anderson Cancer Center, Houston, TX., Moynihan TJ; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Nangia J; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Tung N; Beth Israel Deaconess Medical Center, Boston, MA., Burns R; The Emmes Corporation, Rockville, MD., Rimawi MF; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wolff AC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2020 Apr; Vol. 20 (2), pp. 145-151.e2. Date of Electronic Publication: 2019 Aug 22.
Autor:
Freedman RA; 1 Dana-Farber Cancer Institute, Boston, MA., Gelman RS; 1 Dana-Farber Cancer Institute, Boston, MA., Anders CK; 2 University of North Carolina at Chapel Hill, Chapel Hill, NC., Melisko ME; 3 University of California at San Francisco, San Francisco, CA., Parsons HA; 1 Dana-Farber Cancer Institute, Boston, MA., Cropp AM; 1 Dana-Farber Cancer Institute, Boston, MA., Silvestri K; 1 Dana-Farber Cancer Institute, Boston, MA., Cotter CM; 1 Dana-Farber Cancer Institute, Boston, MA., Componeschi KP; 1 Dana-Farber Cancer Institute, Boston, MA., Marte JM; 1 Dana-Farber Cancer Institute, Boston, MA., Connolly RM; 4 Johns Hopkins School of Medicine, Baltimore, MD., Moy B; 5 Massachusetts General Hospital, Boston, MA., Van Poznak CH; 6 University of Michigan, Ann Arbor, MI., Blackwell KL; 7 Duke University Medical Center, Durham, NC., Puhalla SL; 8 University of Pittsburgh Cancer Institute, Pittsburgh, PA., Jankowitz RC; 8 University of Pittsburgh Cancer Institute, Pittsburgh, PA., Smith KL; 4 Johns Hopkins School of Medicine, Baltimore, MD., Ibrahim N; 9 The University of Texas MD Anderson Cancer Center, Houston, TX., Moynihan TJ; 10 Mayo Clinic, Rochester, MN., O'Sullivan CC; 10 Mayo Clinic, Rochester, MN., Nangia J; 11 Baylor College of Medicine, Houston, TX., Niravath P; 11 Baylor College of Medicine, Houston, TX., Tung N; 12 Beth Israel Deaconess Medical Center, Boston, MA., Pohlmann PR; 13 Lombardi Comprehensive Cancer Center, Washington, DC., Burns R; 14 The Emmes Corporation, Rockville, MD., Rimawi MF; 11 Baylor College of Medicine, Houston, TX., Krop IE; 1 Dana-Farber Cancer Institute, Boston, MA., Wolff AC; 4 Johns Hopkins School of Medicine, Baltimore, MD., Winer EP; 1 Dana-Farber Cancer Institute, Boston, MA., Lin NU; 1 Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 May 01; Vol. 37 (13), pp. 1081-1089. Date of Electronic Publication: 2019 Mar 12.
Autor:
Bresk CA; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria. ANIKA.BRESK@I-MED.AC.AT., Hofer T; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria. tamara.hofer@i-med.ac.at.; Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, 6020 Innsbruck, Austria. tamara.hofer@i-med.ac.at., Wilmschen S; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria. sarah.wilmschen@i-med.ac.at., Krismer M; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria. marina.krismer@gmail.com., Beierfuß A; Central Laboratory Animal Facility, Medical University of Innsbruck, 6020 Innsbruck, Austria. Anja.Beierfuss@i-med.ac.at., Effantin G; Institut de Biologie Structurale (IBS), CNRS, CEA, Université Grenoble Alpes, 38044 Grenoble, France. gregory.effantin@ibs.fr., Weissenhorn W; Institut de Biologie Structurale (IBS), CNRS, CEA, Université Grenoble Alpes, 38044 Grenoble, France. winfried.weissenhorn@ibs.fr., Hogan MJ; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. hoganm@email.chop.edu., Jordan APO; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. andreado@pennmedicine.upenn.edu., Gelman RS; Dana-Farber Cancer Institute, Harvard Medical School and Harvard School of Public Health, Boston, MA 02215, USA. gelman@jimmy.harvard.edu., Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. david.montefiori@duke.edu., Liao HX; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. l.liao@duke.edu., Schmitz JE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA. joern.e.schmitz@gmail.com., Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. barton.haynes@duke.edu., von Laer D; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria. Dorothee.von-Laer@i-med.ac.at., Kimpel J; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria. Janine.kimpel@i-med.ac.at.
Publikováno v:
Viruses [Viruses] 2019 Feb 15; Vol. 11 (2). Date of Electronic Publication: 2019 Feb 15.
Autor:
Li AG; Department of Genetics, Harvard Medical School, Boston, MA 02115; andrew_li@dfci.harvard.edu david_livingston@dfci.harvard.edu.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215., Murphy EC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215., Culhane AC; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115., Powell E; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Wang H; Department of Genetics, Harvard Medical School, Boston, MA 02115.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215., Bronson RT; Department of Pathology, Harvard Medical School, Boston, MA 02115., Von T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215., Giobbie-Hurder A; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215., Gelman RS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115., Briggs KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Piwnica-Worms H; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Zhao JJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Howard Hughes Medical Institute, Chevy Chase, MD 20815., Livingston DM; Department of Genetics, Harvard Medical School, Boston, MA 02115; andrew_li@dfci.harvard.edu david_livingston@dfci.harvard.edu.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Oct 09; Vol. 115 (41), pp. E9600-E9609. Date of Electronic Publication: 2018 Sep 25.
Autor:
Ojikutu BO; 1 Division of Global Health Equity, Brigham and Women's Hospital , Boston, Massachusetts.; 2 John Snow Research and Training Institute , Boston, Massachusetts.; 3 Harvard Medical School , Boston, Massachusetts., Mazzola E; 4 Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute , Boston, Massachusetts., Fullem A; 2 John Snow Research and Training Institute , Boston, Massachusetts., Vega R; 2 John Snow Research and Training Institute , Boston, Massachusetts., Landers S; 2 John Snow Research and Training Institute , Boston, Massachusetts., Gelman RS; 3 Harvard Medical School , Boston, Massachusetts.; 4 Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute , Boston, Massachusetts., Bogart LM; 3 Harvard Medical School , Boston, Massachusetts.; 5 Division of General Pediatrics, Department of Medicine, Boston Children's Hospital , Boston, Massachusetts.; 6 RAND Corporation , Santa Monica, California.
Publikováno v:
AIDS patient care and STDs [AIDS Patient Care STDS] 2016 Jul; Vol. 30 (7), pp. 307-14.